These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 24686117)

  • 21. Protein aggregate spreading in neurodegenerative diseases: problems and perspectives.
    Lee SJ; Lim HS; Masliah E; Lee HJ
    Neurosci Res; 2011 Aug; 70(4):339-48. PubMed ID: 21624403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Nucleolus as a Proteostasis Regulator.
    Amer-Sarsour F; Ashkenazi A
    Trends Cell Biol; 2019 Nov; 29(11):849-851. PubMed ID: 31473054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ALS-linked misfolded SOD1 species have divergent impacts on mitochondria.
    Pickles S; Semmler S; Broom HR; Destroismaisons L; Legroux L; Arbour N; Meiering E; Cashman NR; Vande Velde C
    Acta Neuropathol Commun; 2016 Apr; 4(1):43. PubMed ID: 27121871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Propagating sticky matters: an update on "prion-like" templated misfolding in neurodegenerative disorders.
    Frank S; Tolnay M
    Brain Pathol; 2013 May; 23(3):319-20. PubMed ID: 23587137
    [No Abstract]   [Full Text] [Related]  

  • 25. Quality control of mislocalized and orphan proteins.
    Kong KE; Coelho JPL; Feige MJ; Khmelinskii A
    Exp Cell Res; 2021 Jun; 403(2):112617. PubMed ID: 33930402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. From autophagy to mitophagy: the roles of P62 in neurodegenerative diseases.
    Liu H; Dai C; Fan Y; Guo B; Ren K; Sun T; Wang W
    J Bioenerg Biomembr; 2017 Oct; 49(5):413-422. PubMed ID: 28975445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurological disorders and mitochondria.
    Cabral-Costa JV; Kowaltowski AJ
    Mol Aspects Med; 2020 Feb; 71():100826. PubMed ID: 31630771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro studies in VCP-associated multisystem proteinopathy suggest altered mitochondrial bioenergetics.
    Nalbandian A; Llewellyn KJ; Gomez A; Walker N; Su H; Dunnigan A; Chwa M; Vesa J; Kenney MC; Kimonis VE
    Mitochondrion; 2015 May; 22():1-8. PubMed ID: 25724235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitochondria at the interface between neurodegeneration and neuroinflammation.
    Bader V; Winklhofer KF
    Semin Cell Dev Biol; 2020 Mar; 99():163-171. PubMed ID: 31154011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What do over-trained athletes and patients with neurodegenerative diseases have in common? Mitochondrial dysfunction.
    Ostojic SM; Ratgeber L; Olah A; Betlehem J; Pongras A
    Exp Biol Med (Maywood); 2021 Jun; 246(11):1241-1243. PubMed ID: 33554650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strain diversity in neurodegenerative disease: an argument for a personalized medicine approach to diagnosis and treatment.
    Woerman AL
    Acta Neuropathol; 2021 Jul; 142(1):1-3. PubMed ID: 33891174
    [No Abstract]   [Full Text] [Related]  

  • 32. Lipid Assemblies at the Crossroads of Aging, Proteostasis, and Neurodegeneration.
    Roitenberg N; Cohen E
    Trends Cell Biol; 2019 Dec; 29(12):954-963. PubMed ID: 31669295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What role does mitochondrial stress play in neurodegenerative diseases?
    Pickrell AM; Moraes CT
    Methods Mol Biol; 2010; 648():63-78. PubMed ID: 20700705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Guidelines on experimental methods to assess mitochondrial dysfunction in cellular models of neurodegenerative diseases.
    Connolly NMC; Theurey P; Adam-Vizi V; Bazan NG; Bernardi P; Bolaños JP; Culmsee C; Dawson VL; Deshmukh M; Duchen MR; Düssmann H; Fiskum G; Galindo MF; Hardingham GE; Hardwick JM; Jekabsons MB; Jonas EA; Jordán J; Lipton SA; Manfredi G; Mattson MP; McLaughlin B; Methner A; Murphy AN; Murphy MP; Nicholls DG; Polster BM; Pozzan T; Rizzuto R; Satrústegui J; Slack RS; Swanson RA; Swerdlow RH; Will Y; Ying Z; Joselin A; Gioran A; Moreira Pinho C; Watters O; Salvucci M; Llorente-Folch I; Park DS; Bano D; Ankarcrona M; Pizzo P; Prehn JHM
    Cell Death Differ; 2018 Mar; 25(3):542-572. PubMed ID: 29229998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. When good proteins go bad.
    Haelle T
    Sci Am; 2014 Oct; 311(4):19-20. PubMed ID: 25314857
    [No Abstract]   [Full Text] [Related]  

  • 36. Harnessing the power of yeast to unravel the molecular basis of neurodegeneration.
    Tenreiro S; Munder MC; Alberti S; Outeiro TF
    J Neurochem; 2013 Nov; 127(4):438-52. PubMed ID: 23600759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Iron in neurodegenerative disorders of protein misfolding: a case of prion disorders and Parkinson's disease.
    Singh N; Haldar S; Tripathi AK; McElwee MK; Horback K; Beserra A
    Antioxid Redox Signal; 2014 Jul; 21(3):471-84. PubMed ID: 24512387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Importance of the subcellular location of protein deposits in neurodegenerative diseases.
    Bertolotti A
    Curr Opin Neurobiol; 2018 Aug; 51():127-133. PubMed ID: 29631171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitochondrial drug targets in neurodegenerative diseases.
    Lee J
    Bioorg Med Chem Lett; 2016 Feb; 26(3):714-720. PubMed ID: 26806044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurodegeneration as a consequence of failed mitochondrial maintenance.
    Karbowski M; Neutzner A
    Acta Neuropathol; 2012 Feb; 123(2):157-71. PubMed ID: 22143516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.